Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Genetic architectures of proximal and distal colorectal cancer are partly distinct.

Gut

Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, Conti DV, Chen S, Qu C, Lin Y, Barfield R, Baron JA, Cross AJ, Diergaarde B, Duggan D, Harlid S, Imaz L, Kang HM, Levine DM, Perduca V, Perez-Cornago A, Sakoda LC, Schumacher FR, Slattery ML, Toland AE, van Duijnhoven FJB, Van Guelpen B, Agudo A, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Banbury BL, Bassik MC, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Boutron-Ruault MC, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Caan BJ, Campbell PT, Carr PR, Castells A, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Curtis KR, de la Chapelle A, Easton DF, English DR, Feskens EJM, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Jenab M, Jenkins MA, Joshi AD, Keku TO, Kooperberg C, Kühn T, Küry S, Le Marchand L, Lejbkowicz F, Li CI, Li L, Lieb W, Lindblom A, Lindor NM, Männistö S, Markowitz SD, Milne RL, Moreno L, Murphy N, Nassir R, Offit K, Ogino S, Panico S, Parfrey PS, Pearlman R, Pharoah PDP, Phipps AI, Platz EA, Potter JD, Prentice RL, Qi L, Raskin L, Rennert G, Rennert HS, Riboli E, Schafmayer C, Schoen RE, Seminara D, Song M, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Trichopoulou A, Ulrich CM, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Nickerson DA, Scacheri PC, Kundaje A, Casey G, Gruber SB, Hsu L, Moreno V, Hayes RB, Newcomb PA, Peters U.
PMID: 33632709
Gut. 2021 Jul;70(7):1325-1334. doi: 10.1136/gutjnl-2020-321534. Epub 2021 Feb 25.

OBJECTIVE: An understanding of the etiologic heterogeneity of colorectal cancer (CRC) is critical for improving precision prevention, including individualized screening recommendations and the discovery of novel drug targets and repurposable drug candidates for chemoprevention. Known differences in molecular characteristics...

Cite
Huyghe JR, Harrison TA, Bien SA, et al. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 2021;70(7):1325-1334doi: 10.1136/gutjnl-2020-321534.
Huyghe, J. R., Harrison, T. A., Bien, S. A., Hampel, H., Figueiredo, J. C., Schmit, S. L., Conti, D. V., Chen, S., Qu, C., Lin, Y., Barfield, R., Baron, J. A., Cross, A. J., Diergaarde, B., Duggan, D., Harlid, S., Imaz, L., Kang, H. M., Levine, D. M., Perduca, V., Perez-Cornago, A., Sakoda, L. C., Schumacher, F. R., Slattery, M. L., Toland, A. E., van Duijnhoven, F. J. B., Van Guelpen, B., Agudo, A., Albanes, D., Alonso, M. H., Anderson, K., Arnau-Collell, C., Arndt, V., Banbury, B. L., Bassik, M. C., Berndt, S. I., Bézieau, S., Bishop, D. T., Boehm, J., Boeing, H., Boutron-Ruault, M. C., Brenner, H., Brezina, S., Buch, S., Buchanan, D. D., Burnett-Hartman, A., Caan, B. J., Campbell, P. T., Carr, P. R., Castells, A., Castellví-Bel, S., Chan, A. T., Chang-Claude, J., Chanock, S. J., Curtis, K. R., de la Chapelle, A., Easton, D. F., English, D. R., Feskens, E. J. M., Gala, M., Gallinger, S. J., Gauderman, W. J., Giles, G. G., Goodman, P. J., Grady, W. M., Grove, J. S., Gsur, A., Gunter, M. J., Haile, R. W., Hampe, J., Hoffmeister, M., Hopper, J. L., Hsu, W. L., Huang, W. Y., Hudson, T. J., Jenab, M., Jenkins, M. A., Joshi, A. D., Keku, T. O., Kooperberg, C., Kühn, T., Küry, S., Le Marchand, L., Lejbkowicz, F., Li, C. I., Li, L., Lieb, W., Lindblom, A., Lindor, N. M., Männistö, S., Markowitz, S. D., Milne, R. L., Moreno, L., Murphy, N., Nassir, R., Offit, K., Ogino, S., Panico, S., Parfrey, P. S., Pearlman, R., Pharoah, P. D. P., Phipps, A. I., Platz, E. A., Potter, J. D., Prentice, R. L., Qi, L., Raskin, L., Rennert, G., Rennert, H. S., Riboli, E., Schafmayer, C., Schoen, R. E., Seminara, D., Song, M., Su, Y. R., Tangen, C. M., Thibodeau, S. N., Thomas, D. C., Trichopoulou, A., Ulrich, C. M., Visvanathan, K., Vodicka, P., Vodickova, L., Vymetalkova, V., Weigl, K., Weinstein, S. J., White, E., Wolk, A., Woods, M. O., Wu, A. H., Abecasis, G. R., Nickerson, D. A., Scacheri, P. C., Kundaje, A., Casey, G., Gruber, S. B., Hsu, L., Moreno, V., Hayes, R. B., Newcomb, P. A., & Peters, U. (2021). Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut, 70(7), 1325-1334. https://doi.org/10.1136/gutjnl-2020-321534
Huyghe, Jeroen R, et al. "Genetic architectures of proximal and distal colorectal cancer are partly distinct." Gut vol. 70,7 (2021): 1325-1334. doi: https://doi.org/10.1136/gutjnl-2020-321534
Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, Conti DV, Chen S, Qu C, Lin Y, Barfield R, Baron JA, Cross AJ, Diergaarde B, Duggan D, Harlid S, Imaz L, Kang HM, Levine DM, Perduca V, Perez-Cornago A, Sakoda LC, Schumacher FR, Slattery ML, Toland AE, van Duijnhoven FJB, Van Guelpen B, Agudo A, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Banbury BL, Bassik MC, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Boutron-Ruault MC, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Caan BJ, Campbell PT, Carr PR, Castells A, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Curtis KR, de la Chapelle A, Easton DF, English DR, Feskens EJM, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Jenab M, Jenkins MA, Joshi AD, Keku TO, Kooperberg C, Kühn T, Küry S, Le Marchand L, Lejbkowicz F, Li CI, Li L, Lieb W, Lindblom A, Lindor NM, Männistö S, Markowitz SD, Milne RL, Moreno L, Murphy N, Nassir R, Offit K, Ogino S, Panico S, Parfrey PS, Pearlman R, Pharoah PDP, Phipps AI, Platz EA, Potter JD, Prentice RL, Qi L, Raskin L, Rennert G, Rennert HS, Riboli E, Schafmayer C, Schoen RE, Seminara D, Song M, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Trichopoulou A, Ulrich CM, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Nickerson DA, Scacheri PC, Kundaje A, Casey G, Gruber SB, Hsu L, Moreno V, Hayes RB, Newcomb PA, Peters U. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 2021 Jul;70(7):1325-1334. doi: 10.1136/gutjnl-2020-321534. Epub 2021 Feb 25. PMID: 33632709; PMCID: PMC8223655.
Copy Download .nbib Format: NLM
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset.

Cancers

Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S.
PMID: 34359718
Cancers (Basel). 2021 Jul 29;13(15). doi: 10.3390/cancers13153817.

Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (

Cite
Himbert C, Figueiredo JC, Shibata D, et al. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel). 2021;13(15)doi: 10.3390/cancers13153817.
Himbert, C., Figueiredo, J. C., Shibata, D., Ose, J., Lin, T., Huang, L. C., Peoples, A. R., Scaife, C. L., Pickron, B., Lambert, L., Cohan, J. N., Bronner, M., Felder, S., Sanchez, J., Dessureault, S., Coppola, D., Hoffman, D. M., Nasseri, Y. F., Decker, R. W., Zaghiyan, K., Murrell, Z. A., Hendifar, A., Gong, J., Firoozmand, E., Gangi, A., Moore, B. A., Cologne, K. G., El-Masry, M. S., Hinkle, N., Monroe, J., Mutch, M., Bernadt, C., Chatterjee, D., Sinanan, M., Cohen, S. A., Wallin, U., Grady, W. M., Lampe, P. D., Reddi, D., Krane, M., Fichera, A., Moonka, R., Herpel, E., Schirmacher, P., Kloor, M., von Knebel-Doeberitz, M., Nattenmueller, J., Kauczor, H. U., Swanson, E., Jedrzkiewicz, J., Schmit, S. L., Gigic, B., Ulrich, A. B., Toriola, A. T., Siegel, E. M., Li, C. I., Ulrich, C. M., & Hardikar, S. (2021). Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers, 13(15), . https://doi.org/10.3390/cancers13153817
Himbert, Caroline, et al. "Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset." Cancers vol. 13,15 (2021). doi: https://doi.org/10.3390/cancers13153817
Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel). 2021 Jul 29;13(15). doi: 10.3390/cancers13153817. PMID: 34359718; PMCID: PMC8345133.
Copy Download .nbib Format: NLM
Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery.

Life (Basel, Switzerland)

Schmitt FCF, Schneider M, Mathejczyk W, Weigand MA, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Ulrich AB, Boutin S, Gigic B.
PMID: 33809741
Life (Basel). 2021 Mar 16;11(3). doi: 10.3390/life11030246.

Changes in the gut microbiome have already been associated with postoperative complications in major abdominal surgery. However, it is still unclear whether these changes are transient or a long-lasting effect. Therefore, the aim of this prospective clinical pilot study...

Cite
Schmitt FCF, Schneider M, Mathejczyk W, et al. Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life (Basel). 2021;11(3)doi: 10.3390/life11030246.
Schmitt, F. C. F., Schneider, M., Mathejczyk, W., Weigand, M. A., Figueiredo, J. C., Li, C. I., Shibata, D., Siegel, E. M., Toriola, A. T., Ulrich, C. M., Ulrich, A. B., Boutin, S., & Gigic, B. (2021). Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life (Basel, Switzerland), 11(3), . https://doi.org/10.3390/life11030246
Schmitt, Felix C F, et al. "Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery." Life (Basel, Switzerland) vol. 11,3 (2021). doi: https://doi.org/10.3390/life11030246
Schmitt FCF, Schneider M, Mathejczyk W, Weigand MA, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Ulrich AB, Boutin S, Gigic B. Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life (Basel). 2021 Mar 16;11(3). doi: 10.3390/life11030246. PMID: 33809741; PMCID: PMC8002283.
Copy Download .nbib Format: NLM
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Biltaji E, Walker B, Au TH, Rivers Z, Ose J, Li CI, Brixner DI, Stenehjem DD, Ulrich CM.
PMID: 33849967
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1106-1113. doi: 10.1158/1055-9965.EPI-19-1580. Epub 2021 Apr 13.

BACKGROUND: Inherited genetic variants can modify the cancer-chemopreventive effect of aspirin. We evaluated the clinical and economic value of genotype-guided aspirin use for colorectal cancer chemoprevention in average-risk individuals.METHODS: A decision analytical model compared genotype-guided aspirin use versus no...

Cite
Biltaji E, Walker B, Au TH, et al. Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1106-1113doi: 10.1158/1055-9965.EPI-19-1580.
Biltaji, E., Walker, B., Au, T. H., Rivers, Z., Ose, J., Li, C. I., Brixner, D. I., Stenehjem, D. D., & Ulrich, C. M. (2021). Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(6), 1106-1113. https://doi.org/10.1158/1055-9965.EPI-19-1580
Biltaji, Eman, et al. "Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,6 (2021): 1106-1113. doi: https://doi.org/10.1158/1055-9965.EPI-19-1580
Biltaji E, Walker B, Au TH, Rivers Z, Ose J, Li CI, Brixner DI, Stenehjem DD, Ulrich CM. Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?. Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1106-1113. doi: 10.1158/1055-9965.EPI-19-1580. Epub 2021 Apr 13. PMID: 33849967; PMCID: PMC8172453.
Copy Download .nbib Format: NLM
Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.

Metabolomics : Official journal of the Metabolomic Society

Delphan M, Lin T, Liesenfeld DB, Nattenmüller J, Böhm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose J.
PMID: 29706852
Metabolomics. 2018 Mar;2018(14):22. doi: 10.1007/s11306-017-1314-8. Epub 2018 Jan 31.

BACKGROUND: Branched-chain amino acids (BCAA) have been previously linked to survival in colorectal cancer (CRC) patients. It is unclear whether BCAAs are prognostic biomarkers or surrogate markers for energy balance.OBJECTIVES: We aimed to determine correlations of BCAAs with markers...

Cite
Delphan M, Lin T, Liesenfeld DB, et al. Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study. Metabolomics. 2018;2018(14):22doi: 10.1007/s11306-017-1314-8.
Delphan, M., Lin, T., Liesenfeld, D. B., Nattenmüller, J., Böhm, J. T., Gigic, B., Habermann, N., Zielske, L., Schrotz-King, P., Schneider, M., Ulrich, A., Kauczor, H. U., Ulrich, C. M., & Ose, J. (2018). Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study. Metabolomics : Official journal of the Metabolomic Society, 2018(14), 22. https://doi.org/10.1007/s11306-017-1314-8
Delphan, Mahmoud, et al. "Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study." Metabolomics : Official journal of the Metabolomic Society vol. 2018,14 (2018): 22. doi: https://doi.org/10.1007/s11306-017-1314-8
Delphan M, Lin T, Liesenfeld DB, Nattenmüller J, Böhm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose J. Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study. Metabolomics. 2018 Mar;2018(14):22. doi: 10.1007/s11306-017-1314-8. Epub 2018 Jan 31. PMID: 29706852; PMCID: PMC5922458.
Copy Download .nbib Format: NLM
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

Clinical colorectal cancer

Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J.
PMID: 33935016
Clin Colorectal Cancer. 2021 Sep;20(3):e165-e172. doi: 10.1016/j.clcc.2021.02.007. Epub 2021 Feb 27.

BACKGROUND: Fusobacterium nucleatum (Fn), a bacterium associated with a wide spectrum of infections, has emerged as a key microbe in colorectal carcinogenesis. However, the underlying mechanisms and clinical relevance of Fn in colorectal cancer (CRC) remain incompletely understood.PATIENTS AND...

Cite
Eisele Y, Mallea PM, Gigic B, et al. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer. 2021;20(3):e165-e172doi: 10.1016/j.clcc.2021.02.007.
Eisele, Y., Mallea, P. M., Gigic, B., Stephens, W. Z., Warby, C. A., Buhrke, K., Lin, T., Boehm, J., Schrotz-King, P., Hardikar, S., Huang, L. C., Pickron, T. B., Scaife, C. L., Viskochil, R., Koelsch, T., Peoples, A. R., Pletneva, M. A., Bronner, M., Schneider, M., Ulrich, A. B., Swanson, E. A., Toriola, A. T., Shibata, D., Li, C. I., Siegel, E. M., Figueiredo, J., Janssen, K. P., Hauner, H., Round, J., Ulrich, C. M., Holowatyj, A. N., & Ose, J. (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clinical colorectal cancer, 20(3), e165-e172. https://doi.org/10.1016/j.clcc.2021.02.007
Eisele, Yannick, et al. "Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study." Clinical colorectal cancer vol. 20,3 (2021): e165-e172. doi: https://doi.org/10.1016/j.clcc.2021.02.007
Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer. 2021 Sep;20(3):e165-e172. doi: 10.1016/j.clcc.2021.02.007. Epub 2021 Feb 27. PMID: 33935016; PMCID: PMC8390557.
Copy Download .nbib Format: NLM
Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study.

Journal of the National Comprehensive Cancer Network : JNCCN

Ose DJ, Viskochil R, Holowatyj AN, Larson M, Wilson D, Dunson WA, Deshmukh VG, Butcher JR, Taylor BR, Svoboda K, Leiser J, Tingey B, Haaland B, Wetter DW, Fisher SJ, Hashibe M, Ulrich CM.
PMID: 34129522
J Natl Compr Canc Netw. 2021 Mar 10;19(6):709-718. doi: 10.6004/jnccn.2020.7653.

BACKGROUND: This study aimed to understand the prevalence of prediabetes (preDM) and diabetes mellitus (DM) in patients with cancer overall and by tumor site, cancer treatment, and time point in the cancer continuum.METHODS: This cohort study was conducted at...

Cite
Ose DJ, Viskochil R, Holowatyj AN, et al. Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study. J Natl Compr Canc Netw. 2021;19(6):709-718doi: 10.6004/jnccn.2020.7653.
Ose, D. J., Viskochil, R., Holowatyj, A. N., Larson, M., Wilson, D., Dunson, W. A., Deshmukh, V. G., Butcher, J. R., Taylor, B. R., Svoboda, K., Leiser, J., Tingey, B., Haaland, B., Wetter, D. W., Fisher, S. J., Hashibe, M., & Ulrich, C. M. (2021). Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study. Journal of the National Comprehensive Cancer Network : JNCCN, 19(6), 709-718. https://doi.org/10.6004/jnccn.2020.7653
Ose, Dominik J, et al. "Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study." Journal of the National Comprehensive Cancer Network : JNCCN vol. 19,6 (2021): 709-718. doi: https://doi.org/10.6004/jnccn.2020.7653
Ose DJ, Viskochil R, Holowatyj AN, Larson M, Wilson D, Dunson WA, Deshmukh VG, Butcher JR, Taylor BR, Svoboda K, Leiser J, Tingey B, Haaland B, Wetter DW, Fisher SJ, Hashibe M, Ulrich CM. Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study. J Natl Compr Canc Netw. 2021 Mar 10;19(6):709-718. doi: 10.6004/jnccn.2020.7653. PMID: 34129522; PMCID: PMC8691450.
Copy Download .nbib Format: NLM
Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival.

JNCI cancer spectrum

Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Böhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grünberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Kölsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E.
PMID: 33134831
JNCI Cancer Spectr. 2020 Jul 07;4(5):pkaa051. doi: 10.1093/jncics/pkaa051. eCollection 2020 Oct.

BACKGROUND: Folates, including folic acid, may play a dual role in colorectal cancer development. Folate is suggested to be protective in early carcinogenesis but could accelerate growth of premalignant lesions or micrometastases. Whether circulating concentrations of folate and folic...

Cite
Geijsen AJMR, Ulvik A, Gigic B, et al. Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr. 2020;4(5):pkaa051doi: 10.1093/jncics/pkaa051.
Geijsen, A. J. M. R., Ulvik, A., Gigic, B., Kok, D. E., van Duijnhoven, F. J. B., Holowatyj, A. N., Brezina, S., van Roekel, E. H., Baierl, A., Bergmann, M. M., Böhm, J., Bours, M. J. L., Brenner, H., Breukink, S. O., Bronner, M. P., Chang-Claude, J., de Wilt, J. H. W., Grady, W. M., Grünberger, T., Gumpenberger, T., Herpel, E., Hoffmeister, M., Huang, L. C., Jedrzkiewicz, J. D., Keulen, E. T. P., Kiblawi, R., Kölsch, T., Koole, J. L., Kosma, K., Kouwenhoven, E. A., Kruyt, F. M., Kvalheim, G., Li, C. I., Lin, T., Ose, J., Pickron, T. B., Scaife, C. L., Schirmacher, P., Schneider, M. A., Schrotz-King, P., Singer, M. C., Swanson, E. R., van Duijvendijk, P., van Halteren, H. K., van Zutphen, M., Vickers, K., Vogelaar, F. J., Wesselink, E., Habermann, N., Ulrich, A. B., Ueland, P. M., Weijenberg, M. P., Gsur, A., Ulrich, C. M., & Kampman, E. (2020). Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI cancer spectrum, 4(5), pkaa051. https://doi.org/10.1093/jncics/pkaa051
Geijsen, Anne J M R, et al. "Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival." JNCI cancer spectrum vol. 4,5 (2020): pkaa051. doi: https://doi.org/10.1093/jncics/pkaa051
Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Böhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grünberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Kölsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E. Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr. 2020 Jul 07;4(5):pkaa051. doi: 10.1093/jncics/pkaa051. eCollection 2020 Oct. PMID: 33134831; PMCID: PMC7583160.
Copy Download .nbib Format: NLM
Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study.

Journal of nutritional science

Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady W.
PMID: 25191595
J Nutr Sci. 2013 Apr 09;2:e9. doi: 10.1017/jns.2012.28. eCollection 2013.

Vitamin D and folate are associated with decreased colorectal cancer risk and their association with colorectal cancer prognosis is under investigation. We assessed the levels of plasma 25-hydroxyvitamin D3 (25(OH)D3), folate and vitamin B12 in an international pilot study...

Cite
Ulrich CM, Toriola AT, Siegel EM, et al. Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. J Nutr Sci. 2013;2:e9doi: 10.1017/jns.2012.28.
Ulrich, C. M., Toriola, A. T., Siegel, E. M., Brenner, H., Chang-Claude, J., Abbenhardt, C., Kotzmann, J., Song, X., Owen, R. W., Hoffmeister, M., Becher, H., Shibata, D., Vickers, K., Rush, S. K., Makar, K., Würtele, G., Haubner, R., Sellers, T. A., & Grady, W. (2013). Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. Journal of nutritional science, 2e9. https://doi.org/10.1017/jns.2012.28
Ulrich, Cornelia M, et al. "Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study." Journal of nutritional science vol. 2 (2013): e9. doi: https://doi.org/10.1017/jns.2012.28
Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady W. Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. J Nutr Sci. 2013 Apr 09;2:e9. doi: 10.1017/jns.2012.28. eCollection 2013. PMID: 25191595; PMCID: PMC4153124.
Copy Download .nbib Format: NLM
Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study.

Metabolites

Ose J, Gigic B, Lin T, Liesenfeld DB, Böhm J, Nattenmüller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Toriola AT, Siegel EM, Schmit S, Schneider M, Ulrich A, Kauczor HU, Ulrich CM.
PMID: 31500101
Metabolites. 2019 Sep 06;9(9). doi: 10.3390/metabo9090178.

Cachexia is a multifactorial syndrome that is characterized by loss of skeletal muscle mass in cancer patients. The biological pathways involved remain poorly characterized. Here, we compare urinary metabolic profiles in newly diagnosed colorectal cancer patients (stage I-IV) from...

Cite
Ose J, Gigic B, Lin T, et al. Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites. 2019;9(9)doi: 10.3390/metabo9090178.
Ose, J., Gigic, B., Lin, T., Liesenfeld, D. B., Böhm, J., Nattenmüller, J., Scherer, D., Zielske, L., Schrotz-King, P., Habermann, N., Ochs-Balcom, H. M., Peoples, A. R., Hardikar, S., Li, C. I., Shibata, D., Figueiredo, J., Toriola, A. T., Siegel, E. M., Schmit, S., Schneider, M., Ulrich, A., Kauczor, H. U., & Ulrich, C. M. (2019). Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites, 9(9), . https://doi.org/10.3390/metabo9090178
Ose, Jennifer, et al. "Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study." Metabolites vol. 9,9 (2019). doi: https://doi.org/10.3390/metabo9090178
Ose J, Gigic B, Lin T, Liesenfeld DB, Böhm J, Nattenmüller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Toriola AT, Siegel EM, Schmit S, Schneider M, Ulrich A, Kauczor HU, Ulrich CM. Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites. 2019 Sep 06;9(9). doi: 10.3390/metabo9090178. PMID: 31500101; PMCID: PMC6780796.
Copy Download .nbib Format: NLM
Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, Papadimitriou N, Bishop DT, Casey G, Colorado-Yohar SM, Cotterchio M, Cross AJ, Marchand LL, Lin Y, Offit K, Onland-Moret NC, Peters U, Potter JD, Rohan TE, Weiderpass E, Gunter MJ, Murphy N.
PMID: 33879453
Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1336-1348. doi: 10.1158/1055-9965.EPI-20-1690. Epub 2021 Apr 20.

BACKGROUND: Epidemiologic studies evaluating associations between sex steroid hormones and colorectal cancer risk have yielded inconsistent results. To elucidate the role of circulating levels of testosterone, and sex hormone-binding globulin (SHBG) in colorectal cancer risk, we conducted observational and...

Cite
Dimou N, Mori N, Harlid S, et al. Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1336-1348doi: 10.1158/1055-9965.EPI-20-1690.
Dimou, N., Mori, N., Harlid, S., Harbs, J., Martin, R. M., Smith-Byrne, K., Papadimitriou, N., Bishop, D. T., Casey, G., Colorado-Yohar, S. M., Cotterchio, M., Cross, A. J., Marchand, L. L., Lin, Y., Offit, K., Onland-Moret, N. C., Peters, U., Potter, J. D., Rohan, T. E., Weiderpass, E., Gunter, M. J., & Murphy, N. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(7), 1336-1348. https://doi.org/10.1158/1055-9965.EPI-20-1690
Dimou, Niki, et al. "Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,7 (2021): 1336-1348. doi: https://doi.org/10.1158/1055-9965.EPI-20-1690
Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, Papadimitriou N, Bishop DT, Casey G, Colorado-Yohar SM, Cotterchio M, Cross AJ, Marchand LL, Lin Y, Offit K, Onland-Moret NC, Peters U, Potter JD, Rohan TE, Weiderpass E, Gunter MJ, Murphy N. Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1336-1348. doi: 10.1158/1055-9965.EPI-20-1690. Epub 2021 Apr 20. PMID: 33879453.
Copy Download .nbib Format: NLM
Impact of the COVID-19 pandemic on exercise habits among cancer patients.

Research square

Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR.
PMID: 34580667
Res Sq. 2021 Sep 21; doi: 10.21203/rs.3.rs-704646/v1.

Purpose There is limited information on how the COVID-19 pandemic has changed health behaviors among cancer patients. We examined the impact of the pandemic on changes in exercise behaviors and identified characteristics associated with these changes among cancer patients....

Cite
Himbert C, Hathaway CA, Daniels B, et al. Impact of the COVID-19 pandemic on exercise habits among cancer patients. Res Sq. 2021;doi: 10.21203/rs.3.rs-704646/v1.
Himbert, C., Hathaway, C. A., Daniels, B., Salas, K., Ashworth, A., Gigic, B., Lin, T., Viskochil, R., Kirchhoff, A. C., Grossman, D., Ose, J., Tward, J., Scaife, C., Figueiredo, J. C., Toriola, A. T., Beck, A., Shibata, D., Gonzalez, B. D., Matsen, C., Christenson, C., Ma, D. S., Colman, H., Hunt, J. P., Jones, K. B., Lee, C. J., Larson, M., Onega, T., Akerley, W. L., Li, C. I., Schneider, M., Penedo, F. J., Siegel, E. M., Tworoger, S. S., Ulrich, C. M., & Peoples, A. R. (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. Research square, . https://doi.org/10.21203/rs.3.rs-704646/v1
Himbert, Caroline, et al. "Impact of the COVID-19 pandemic on exercise habits among cancer patients." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-704646/v1
Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR. Impact of the COVID-19 pandemic on exercise habits among cancer patients. Res Sq. 2021 Sep 21; doi: 10.21203/rs.3.rs-704646/v1. PMID: 34580667; PMCID: PMC8475966.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries